Trial Profile
A placebo controlled study to test the effectiveness of atorvastatin and irbesartan on infarct size, cerebral perfusion, cerebral response to ischaemia and clinical outcome in acute ischaemic stroke.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Irbesartan (Primary)
- Indications Cardiovascular disorders; Stroke
- Focus Therapeutic Use
- Acronyms ASTART
- 26 Sep 2009 New trial record